⌘K

Home/Filings/4/A/0001209191-17-021449

4/A//SEC Filing

CYTORI THERAPEUTICS, INC. 4/A

Accession 0001209191-17-021449

$PSTVCIK 0001095981operating

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 5:07 PM ET

Size

5.7 KB

Accession

0001209191-17-021449

Insider Transaction Report

Form 4/AAmended

Period: 2017-03-08

CYTORI THERAPEUTICS, INC.CTYX

HARRIS JOHN DAVID

VP and GM Cell Therapy

Transactions

Award
Incentive Stock Option (right to buy)
2017-03-08+31,100→ 31,100 total
Exercise: $1.55Exp: 2027-03-08→ Common Stock (31,100 underlying)

Footnotes (1)

[F1]Option shares shall vest and become exercisable over four (4) years in forty-eight consecutive monthly installments.

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION

Issuer

CYTORI THERAPEUTICS, INC.

CIK 0001095981

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001095981

Filing Metadata

Form type: 4/A
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 5:07 PM ET
Size: 5.7 KB

View on SEC.gov